全球動物疫苗市場按動物類型、技術、給藥途徑、分銷管道和地區分類

Veterinary Vaccines Market, By Animal Type, By Technology, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球獸用疫苗市場價值預估為 104.6 億美元，預計到 2032 年將達到 177 億美元，2025 年至 2032 年的複合年成長率為 7.8%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	104.6億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	7.80％	2032 年價值預測	177億美元

圖。

獸用疫苗是給動物施用的生物製藥，以刺激免疫系統並提供對疾病的主動免疫。疫苗接種可以保護單一動物感染疾病，並間接形成保護整個群體的群體免疫。過去幾十年來，隨著寵物成為人們家庭中不可或缺的一部分，人們的動物保健意識不斷增強，帶動全球獸用疫苗市場迅速擴張。此外，政府也強制要求給牲畜和寵物接種疫苗。疫苗接種和重組基因技術的發展使製造商能夠開發出針對多種通用感染疾病的有效疫苗。

市場動態：

全球獸醫疫苗市場受到寵物擁有量增加、動物保健支出增加、政府對動物疾病控制的舉措、通用感染疾病風險增加以及畜牧業集約化等因素的推動。然而，疫苗生產成本高、法規嚴格以及一些地區缺乏必要的基礎設施和專業知識，阻礙了市場的成長。輸送系統、治療方法和表位圖譜的進步為獸醫疫苗市場提供了機會。製藥公司正在開發重組蛋白和抗毒素，以有效預防豬瘟、禽流感、狂犬病和牛結核病，這些疾病對動物和公眾健康構成重大威脅。單劑量製劑和無針一體式注射器的推出旨在降低疫苗接種成本並提高便利性。

本研究的主要特點

本報告對全球動物疫苗市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球動物疫苗市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球動物疫苗市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球動物疫苗市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 10.46 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.80%	2032 Value Projection:	USD 17.70 Bn

Veterinary vaccines are biological preparations administered to animals in order to stimulate the immune system and provide active immunity against a disease. Vaccination protects individual animals from infectious diseases and generates herd immunity which indirectly protects the whole community. The global veterinary vaccine market has shown rapid expansion over the past few decades driven by the increasing awareness about animal healthcare as pets have become an integral part of people's families. Government mandates in various countries have also encouraged vaccination of livestock and companion animals. Advancements in vaccination technologies and recombinant procedures have enabled manufacturers to develop efficacious vaccines against a wide range of zoonotic diseases.

Market Dynamics:

The global veterinary vaccine market is driven by factors such as rising pet adoption, growing animal healthcare expenditure, government initiatives for animal disease control, increase in the risk of zoonotic diseases, and intensification of livestock farming. However, high cost of vaccine production, stringent regulations and lack of necessary infrastructure and expertise in some regions constrain market growth. Advancements in delivery systems, therapeutic approaches, and epitope mapping offer opportunities in the veterinary vaccines market. Pharmaceutical companies are developing recombinant protein and antitoxins for effective vaccination against swine fever, bird flu, rabies, and bovine tuberculosis which are major threats to animals as well as public health. Introduction of single-dose formulations and integrated needle-free injectors aim to reduce vaccination costs and improve convenience.

Key Features of the Study:

This report provides an in-depth analysis of the global veterinary vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global veterinary vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Aratana Therapeutics Inc., Regeneus Ltd., Morphogenesis Inc., Karyopharm Therapeutics Inc., Zoetis Inc., Eli Lilly and Company, Merck & Co. Inc., Boehringer Ingelheim GmbH., Elanco Animal Health, Virbac, Hester Biosciences Limited, Ceva Sante Animale, Phibro Animal Health Corporation, Kemin Industries, Inc., Finlab, Vaxxinova , Vira Vaccine Shaya, and VETERQUIMICA SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global veterinary vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccines market.

Market Segmentation

Technology:
- Inactivated Vaccines
- Toxoid Vaccines
- Live Attenuated Vaccines
- Subunit and DNA Vaccines
- Recombinant Vaccines
Animal Type:
- Companion
- Equine
- Canine
- Feline
- Livestock
- Bovine
- Ovine
- Porcine
- Poultry
- Others
Route of Administration:
- Subcutaneous Injection
- Intramuscular Injection
- Intranasal Administration
- Others
Distribution Channel
- Public
- Private
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Aratana Therapeutics Inc.
- Regeneus Ltd.
- Morphogenesis Inc.
- Karyopharm Therapeutics Inc.
- Zoetis Inc.
- Eli Lilly and Company
- Merck & Co. Inc.
- Boehringer Ingelheim GmbH.
- Elanco Animal Health
- Virbac
- Hester Biosciences Limited
- Ceva Sante Animale
- Phibro Animal Health Corporation
- Kemin Industries, Inc.
- Finlab
- Vaxxinova
- Vira Vaccine Shaya
- VETERQUIMICA SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Animal Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Veterinary Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the Market

5. Global Veterinary Vaccine Market, By Technology, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Toxoid Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Live Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Subunit and DNA Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Recombinant Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Veterinary Vaccine Market, By Animal Type, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Companion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Equine
- Canine
- Feline
Livestock
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Bovine
- Ovine
- Porcine
- Poultry
- Others

7. Global Veterinary Vaccine Market, By Route of Administration, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Subcutaneous Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Intramuscular Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Intranasal Administration
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Veterinary Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Veterinary Vaccine Market, By Region, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa

10. Competitive Landscape

Aratana Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneus Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Morphogenesis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Karyopharm Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zoetis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies